GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChromaDex Corp (FRA:OCD1) » Definitions » Cyclically Adjusted PS Ratio

ChromaDex (FRA:OCD1) Cyclically Adjusted PS Ratio : 4.18 (As of May. 16, 2024)


View and export this data going back to 2016. Start your Free Trial

What is ChromaDex Cyclically Adjusted PS Ratio?

As of today (2024-05-16), ChromaDex's current share price is €3.34. ChromaDex's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €0.80. ChromaDex's Cyclically Adjusted PS Ratio for today is 4.18.

The historical rank and industry rank for ChromaDex's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:OCD1' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.5   Med: 7.08   Max: 24.02
Current: 4.09

During the past years, ChromaDex's highest Cyclically Adjusted PS Ratio was 24.02. The lowest was 1.50. And the median was 7.08.

FRA:OCD1's Cyclically Adjusted PS Ratio is ranked better than
57.42% of 512 companies
in the Biotechnology industry
Industry Median: 5.535 vs FRA:OCD1: 4.09

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

ChromaDex's adjusted revenue per share data for the three months ended in Mar. 2024 was €0.271. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €0.80 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


ChromaDex Cyclically Adjusted PS Ratio Historical Data

The historical data trend for ChromaDex's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChromaDex Cyclically Adjusted PS Ratio Chart

ChromaDex Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.05 8.30 5.53 2.16 1.63

ChromaDex Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.88 1.88 1.70 1.63 3.89

Competitive Comparison of ChromaDex's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, ChromaDex's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ChromaDex's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ChromaDex's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where ChromaDex's Cyclically Adjusted PS Ratio falls into.



ChromaDex Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

ChromaDex's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3.34/0.8
=4.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ChromaDex's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, ChromaDex's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.271/129.4194*129.4194
=0.271

Current CPI (Mar. 2024) = 129.4194.

ChromaDex Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.080 100.560 0.103
201409 0.090 100.428 0.116
201412 0.097 99.070 0.127
201503 0.136 99.621 0.177
201506 0.152 100.684 0.195
201509 0.156 100.392 0.201
201512 0.006 99.792 0.008
201603 0.176 100.470 0.227
201606 0.212 101.688 0.270
201609 0.093 101.861 0.118
201612 0.111 101.863 0.141
201703 0.083 102.862 0.104
201706 0.089 103.349 0.111
201709 0.107 104.136 0.133
201712 0.124 104.011 0.154
201803 0.097 105.290 0.119
201806 0.122 106.317 0.149
201809 0.126 106.507 0.153
201812 0.144 105.998 0.176
201903 0.161 107.251 0.194
201906 0.177 108.070 0.212
201909 0.190 108.329 0.227
201912 0.197 108.420 0.235
202003 0.217 108.902 0.258
202006 0.223 108.767 0.265
202009 0.195 109.815 0.230
202012 0.205 109.897 0.241
202103 0.192 111.754 0.222
202106 0.216 114.631 0.244
202109 0.216 115.734 0.242
202112 0.230 117.630 0.253
202203 0.229 121.301 0.244
202206 0.232 125.017 0.240
202209 0.252 125.227 0.260
202212 0.268 125.222 0.277
202303 0.282 127.348 0.287
202306 0.250 128.729 0.251
202309 0.243 129.860 0.242
202312 0.259 129.419 0.259
202403 0.271 129.419 0.271

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


ChromaDex  (FRA:OCD1) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


ChromaDex Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of ChromaDex's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ChromaDex (FRA:OCD1) Business Description

Industry
Traded in Other Exchanges
Address
10900 Wilshire Boulevard, Suite 600, Los Angeles, CA, USA, 90024
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segment namely Consumer Products, Ingredients segment and Analytical Reference Standards and Services. Majority of the revenue is earned from Consumer Products segment.

ChromaDex (FRA:OCD1) Headlines

No Headlines